Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Bureau Veritas S.A.. (2/3/14). "Press Release: Bureau Veritas Completes the Acquisition of Maxxam, Canada’s Market Leader in Analytical Services". Neuilly-sur-Seine.

Organisations Organisation Bureau Veritas S.A.
  Group Bureau Veritas (Group)
  Organisation 2 Maxxam Analytics International Corporation
  Group Bureau Veritas (Group)
Products Product analytical services
  Product 2 private equity
Index term Index term Maxxam Analytics–Bureau Veritas: investment, 201312–201401 acquisition CAD650m from majority shareholder Omers Private Equity
     


Neuilly-sur-Seine, France, February 3, 2014 - Bureau Veritas successfully completed the acquisition of Maxxam Analytics International Corporation on January 31, 2014.

The share purchase agreement was signed by Bureau Veritas and OMERS Private Equity on December 20, 2013, for a consideration of CAD 650 million subject to customary closing conditions including regulatory clearance.

Maxxam operates in three main areas: environmental services, petroleum services and food safety and DNA/forensics services. Canada's market leader, Maxxam has the largest laboratory network in Canada and has approximately 2,500 employees. Maxxam's revenue for the fiscal year ended in March 2013 was CAD 246 million.

The acquisition of Maxxam positions Bureau Veritas as the leader in the Testing, Inspection and Certification (TIC) industry in Canada, a market with strong growth prospects, and expands its portfolio of services with high added-value expertise.

This acquisition is in line with the strategic objectives of the BV2015 plan, including a stronger presence in North America and diversification into new services with solid growth potential.


About Bureau Veritas

Bureau Veritas is a world leader in conformity assessment and certification services. Created in 1828, the Group has 62,000 employees in around 1,330 offices and laboratories located in 140 countries. Bureau Veritas helps its clients to improve their performances by offering services and innovative solutions in order to ensure that their assets, products, infrastructure and processes meet standards and regulations in terms of quality, health and safety, environmental protection and social responsibility.

Bureau Veritas is listed on Euronext Paris and belongs to the Next 20 index.
Compartment A, code ISIN FR 0006174348, stock symbol: BVI.

   
Record changed: 2016-03-19

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Bureau Veritas (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px